睿智医药 (300149.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(睿智医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度每股收益(元) ----1.00-2.00-
 单季度销售毛利率(%) 24.0020.0027.00-12.0039.0028.0040.00
 单季度销售净利率(%) -7.002.00-11.00-219.0019.00315.002.00
 单季度净资产收益率ROE(%) -1.00--1.00-24.002.0039.00-
 单季度总资产净利率ROA(%) -1.00--1.00-15.001.0021.00-
单季度财务摘要:
 单季度营业总收入(元) 288,723,817.00288,795,947.00268,658,645.00294,346,942.00345,340,861.00300,594,595.00386,301,923.00
 单季度营业总成本(元) 307,977,956.00277,931,898.00303,706,249.00414,170,877.00281,579,727.00344,311,770.00368,984,886.00
 单季度营业收入(元) 288,723,817.00288,795,947.00268,658,645.00294,346,942.00345,340,861.00300,594,595.00386,301,923.00
 单季度营业利润(元) -16,171,117.0013,312,735.00-31,830,301.00-635,072,555.0074,555,562.001,312,552,422.0011,449,337.00
 单季度利润总额(元) -16,081,352.0013,354,865.00-31,708,771.00-653,379,235.0074,339,520.001,312,309,444.0011,452,290.00
 单季度净利润(元) -19,504,186.006,750,331.00-28,595,596.00-644,849,930.0066,690,461.00947,120,743.009,416,742.00
 单季度归属母公司股东的净利润(元) -19,427,860.006,791,005.00-28,566,912.00-644,806,822.0066,807,166.00947,113,666.009,470,997.00
 单季度经营活动产生的现金流量(元) 79,249,022.0028,211,289.00-20,654,401.00326,841,040.00-107,113,806.007,788,375.0034,944,776.00
 单季度投资活动产生的现金流量(元) -13,959,865.00-233,771,938.00215,815,098.00-287,775,541.00-67,377,443.001,401,261,828.00-38,329,696.00
 单季度筹资活动产生的现金流量(元) -35,577,090.00-51,340,100.00-269,984,196.00-154,617,422.00-28,924,937.00-580,934,198.00-95,633,226.00
 单季度现金及现金等价物净增加(元) 30,967,789.00-240,419,461.00-85,892,696.00-118,205,499.00-172,097,256.00822,143,727.00-99,410,378.00

前瞻产业研究院